InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,277.51
(
0.80%
)
US TECH 100
18,064.80
(
0.02%
)
Dow Jones
38,686.32
(
1.51%
)
Brent Oil
81.30
(
0.00%
)
Bitcoin
67,754.25
(
0.40%
)
Post# of 439
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 830
Posts 119741
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Wednesday, 08/30/2006 2:11:24 PM

Wednesday, August 30, 2006 2:11:24 PM

Post# of 439
Akzo Nobel Signs Deal to Develop Avian Flu Vaccine

http://yahoo.reuters.com/news/articlehybrid.aspx?storyID=urn:newsml:reuters.com:20060830:MTFH81807_2...

>>
AMSTERDAM, Aug 30 (Reuters) - Dutch chemical group Akzo Nobel NV (AKZOY) said on Wednesday it had signed a research agreement with U.S.-based Centers for Disease Control and Prevention to develop a pandemic avian flu vaccine. "The agreement -- co-signed with Nobilon's international partner, Australian-based BioDiem Ltd -- involves the development of a live attenuated cold-adapted cell culture vaccine against the H5N1 strain of the avian influenza virus," Akzo Nobel said in a statement.
<<

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up